News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Toxikon Expands Analytical Chemistry Services


10/19/2005 5:12:46 PM

BEDFORD, Mass., Feb. 17 /PRNewswire/ -- Toxikon Corporation, a life science testing and consulting firm, announced today that it has completed the consolidation and expansion of its chemistry services for pharmaceutical, medical device, and environmental testing.

"Chemistry, an essential component of our services, has been upgraded to meet the ongoing needs of our key business areas," said Dr. Laxman Desai, CEO. "Consolidating our extensive analytical chemistry capabilities to our new, expanded facilities in Bedford also gives us greater capacity for general and specialty chemistry for ISO 10993, Part 18 for leachables and extractables and other medical device testing," he explained. Dr. Desai also noted that environmental chemistry services remain a growing and vital part of the overall analytical services division.

The company also reported that as part of the expansion bioanalytics services have been added to serve the drug development needs of biotech and pharmaceutical companies in preclinical and clinical studies. Toxikon provides method development and validation as well as high-throughput sample analysis for its clients to support them through drug discovery, preclinical, and clinical studies as well as manufacturing analysis to meet regulatory compliance.

Founded in 1977, Toxikon is a privately owned contract research organization providing toxicology, pharmacology, in-vitro and analytical testing services for companies, research institutions, and government agencies, worldwide. Focused on preclinical and other early stage product and process development, Toxikon helps to assure safety, regulatory compliance, and speed-to-market for clients in biotech, pharmaceuticals, medical device, and chemical industries. Toxikon also provides manufacturing support and test related services post approval.

Toxikon is headquartered in Bedford, MA, and operates testing and laboratory facilities at this location and in Belgium.

Contacts: Laxman Desai 781-275-3330 x104 laxman.desai@toxikon.com Larry Miller 781-275-3330 x121 larry.miller@toxikon.com Ted Agne 781-631-3117 edagne@comstratgroup.com

Toxikon Corporation

CONTACT: Laxman Desai, +1-781-275-3330, ext. 104,laxman.desai@toxikon.com, or Larry Miller, +1-781-275-3330, ext. 121,larry.miller@toxikon.com, both of Toxikon; or Ted Agne, +1-781-631-3117,edagne@comstratgroup.com of Communications Strategy Group


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES